Ipsen

Founders Henri Beaufour

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 12
Average round size
info
The average size of a deal this fund participated in
$44M
Portfolio companies 10
Rounds per year 0.13
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 3
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Drug Discovery
Summary

Ipsen is the famous Corporate Investor, which was founded in 1929. The main office of represented Corporate Investor is situated in the Boulogne-billancourt. The venture was found in Europe in France.

Speaking about the real fund results, this Corporate Investor is 9 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2017. The important activity for fund was in 2019. This Ipsen works on 4 percentage points more the average amount of lead investments comparing to the other organizations.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Ipsen, startups are often financed by New Enterprise Associates, MPM Capital, Third Rock Ventures. The meaningful sponsors for the fund in investment in the same round are Third Rock Ventures, New Enterprise Associates, MPM Capital. In the next rounds fund is usually obtained by Third Rock Ventures, SV Health Investors, Pfizer Venture Investments.

The current fund was established by Henri Beaufour.

Among the most popular fund investment industries, there are Biotechnology, Health Care. Among the various public portfolio startups of the fund, we may underline Thesan Pharmaceuticals, Pyxis Oncology, Pyxis Oncology For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Ipsen:
Typical Co-investors
Ipsen is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Ipsen:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alkermes County Dublin, Dublin, Ireland
Apex Capital New York, New York, United States
Bisheng Keji China, Hangzhou, Zhejiang
Capital One Illinois, United States, Virginia
Dexia Arcisses, Centre-Loire Valley, France
Finpiemonte -
Kerogen Digital Solutions -
Korea Asset Investment Securities -
Lympo California, San Diego, United States
Marubun Corporation Japan, Tokyo
Prudence Investment Management China, Hong Kong, Hong Kong Island
Qianhai Pengchen Investment China, Guangdong, Shenzhen
Ralph T. and Esther L. Warburton Foundation -
Roynat Equity Partners Alberta, Calgary, Canada
SIGMA Ventures Brentwood, Tennessee, United States
Sprout Group New York, New York, United States
Viadeo France, Ile-de-France, Paris

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

BAKX Therapeutics

Health Care
Medical
Therapeutics
$25M18 Nov 2021 Kingston, New York, United States

Pyxis Oncology

Biotechnology
Health Care
Pharmaceutical
$152M30 Mar 2021 Boston, Massachusetts, United States

Xilio Therapeutics

Biotechnology
Health Care
Health Diagnostics
Therapeutics
$100M02 Mar 2020 Massachusetts, United States

Pyxis Oncology

Biotechnology
Health Care
Pharmaceutical
$22M17 Jul 2019 Boston, Massachusetts, United States

Rhythm Pharmaceuticals

Biotechnology
Pharmaceutical
Therapeutics
$41M16 Feb 2017 Boston, Massachusetts, United States

Akkadeas Pharma

Health Care
Pharmaceutical
31 Jan 2017 Lombardy

Purer Skin

Developer Platform
Health Care
Pharmaceutical
$40M13 Aug 2015 Boston, Massachusetts, United States

Thesan Pharmaceuticals

Biopharma
Biotechnology
Drug Discovery
Pharmaceuticals
Therapeutics
$49M24 Feb 2014 Carlsbad, California, United States

Motus Therapeutics

Biotechnology
Health Care
Therapeutics
$8M27 Nov 2012 Boston, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Ipsen?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: